228 related articles for article (PubMed ID: 34997843)
41. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
Kluwe L; Friedrich RE; Mautner VF
Cancer Genet Cytogenet; 1999 Aug; 113(1):65-9. PubMed ID: 10459349
[TBL] [Abstract][Full Text] [Related]
42. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
Legius E; Brems H
Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
[TBL] [Abstract][Full Text] [Related]
43. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
[TBL] [Abstract][Full Text] [Related]
44. High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas.
Asai A; Karnan S; Ota A; Takahashi M; Damdindorj L; Konishi Y; Hossain E; Konishi H; Nagata A; Yokoo K; Hosokawa Y
Gene; 2015 Mar; 558(2):220-6. PubMed ID: 25562418
[TBL] [Abstract][Full Text] [Related]
45. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
[TBL] [Abstract][Full Text] [Related]
46. Circulating free DNA in the plasma of individuals with neurofibromatosis type 1.
Kallionpää RA; Ahramo K; Aaltonen M; Pennanen P; Peltonen J; Peltonen S
Am J Med Genet A; 2021 Apr; 185(4):1098-1104. PubMed ID: 33484105
[TBL] [Abstract][Full Text] [Related]
47. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
48. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.
Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M
Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606
[TBL] [Abstract][Full Text] [Related]
49. How to Distinguish Solitary Neurofibroma From Neurofibromatosis Type 1.
Guo C; Zhou L; Sun Y; Hu X
J Craniofac Surg; 2022 May; 33(3):889-891. PubMed ID: 35727670
[TBL] [Abstract][Full Text] [Related]
50. Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombination.
Bengesser K; Vogt J; Mussotter T; Mautner VF; Messiaen L; Cooper DN; Kehrer-Sawatzki H
Hum Mutat; 2014 Feb; 35(2):215-26. PubMed ID: 24186807
[TBL] [Abstract][Full Text] [Related]
51. Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice.
Feigenbaum L; Fujita K; Collins FS; Jay G
J Virol; 1996 May; 70(5):3280-5. PubMed ID: 8627811
[TBL] [Abstract][Full Text] [Related]
52. Hereditary spinal neurofibromatosis: a rare form of NF1?
Poyhonen M; Leisti EL; Kytölä S; Leisti J
J Med Genet; 1997 Mar; 34(3):184-7. PubMed ID: 9132486
[TBL] [Abstract][Full Text] [Related]
53. Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.
Pacot L; Sabbagh A; Sohier P; Hadjadj D; Ye M; Boland-Auge A; Bacq-Daian D; Laurendeau I; Briand-Suleau A; Deleuze JF; Margueron R; Vidaud M; Ferkal S; Parfait B; Vidaud D; ; Pasmant E; Wolkenstein P
Br J Dermatol; 2024 Jan; 190(2):226-243. PubMed ID: 37831592
[TBL] [Abstract][Full Text] [Related]
54. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
[TBL] [Abstract][Full Text] [Related]
55. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
56. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
57. Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.
Monroe CL; Dahiya S; Gutmann DH
Annu Rev Pathol; 2017 Jan; 12():53-74. PubMed ID: 28135565
[TBL] [Abstract][Full Text] [Related]
58. Microsatellite instability and promoter methylation as possible causes of NF1 gene inactivation in neurofibromas.
Luijten M; Redeker S; van Noesel MM; Troost D; Westerveld A; Hulsebos TJ
Eur J Hum Genet; 2000 Dec; 8(12):939-45. PubMed ID: 11175282
[TBL] [Abstract][Full Text] [Related]
59. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
[TBL] [Abstract][Full Text] [Related]
60. The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1.
Chilibeck CM; Shah S; Russell HC; Vincent AL
Ophthalmic Genet; 2021 Jun; 42(3):223-229. PubMed ID: 33594930
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
